Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017 | Zendy

Alain Farra | Zendy; Alexandre Manirakiza | Zendy; Brice Martial Yambiyo | Zendy; Germain Zandanga | Zendy; Boris Lokoti | Zendy; Alain Berlioz-Arthaud | Zendy; Gilles Ngaya | Zendy; Georges Hermana | Zendy; Louis Médard Ourandji | Zendy; Albert Ignaleamoko | Zendy; Aristide Désiré Komangoya-Nzonzo | Zendy; Jean Pierre Simelo | Zendy; Jean de Dieu Iragena | Zendy

Open Access

Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017

Author(s) -

Alain Farra,

Alexandre Manirakiza,

Brice Martial Yambiyo,

Germain Zandanga,

Boris Lokoti,

Alain Berlioz-Arthaud,

Gilles Ngaya,

Georges Hermana,

Louis Médard Ourandji,

Albert Ignaleamoko,

Aristide Désiré Komangoya-Nzonzo,

Jean Pierre Simelo,

Jean de Dieu Iragena

Publication year - 2019

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofz075

Subject(s) - medicine , genexpert mtb/rif , tuberculosis , rifampicin , odds ratio , confidence interval , drug resistance , mycobacterium tuberculosis , population , multi drug resistant tuberculosis , incidence (geometry) , environmental health , pathology , microbiology and biotechnology , biology , physics , optics

Resistance to rifampicin is still high in the CAR and is most strongly associated with treatment failure. The Ministry of Health must to deploy GeneXpert MTB/RIF tests in the provinces to evaluate resistance to TB drugs in the country.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research